Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment
Authors:
- Beatrice A. ChenBCBeatrice A. Chen
- Leslie A. MeynLMLeslie A. Meyn
- Mitchell D. CreininMCMitchell D. Creinin
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 85 (4) , 402-407
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Abortion Incidence and Access to Services In the United States, 2008Perspectives on Sexual and Reproductive Health, 2011
- Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 daysHuman Reproduction, 2010
- Feasibility of telephone follow-up after medical abortionContraception, 2010
- Medication AbortionClinical Obstetrics and Gynecology, 2009
- Clinical utility of urine pregnancy assays to determine medical abortion outcome is limitedContraception, 2007
- Risk factors for unsuccessful medical abortion with mifepristone and misoprostolActa Obstetricia et Gynecologica Scandinavica, 2007
- WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.BJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Verifying the effectiveness of medical abortion; ultrasound versus hCG testingEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2003
- Mifepristone followed on the same day by vaginal misoprostol for early abortionContraception, 2001
- Abortion with mifepristone and misoprostol: Regimens, efficacy, acceptability and future directionsAmerican Journal of Obstetrics and Gynecology, 2000